Equities

Inozyme Pharma Inc

INZY:NSQ

Inozyme Pharma Inc

Actions
  • Price (USD)5.73
  • Today's Change-0.05 / -0.87%
  • Shares traded191.67k
  • 1 Year change+16.94%
  • Beta1.5154
Data delayed at least 15 minutes, as of Sep 20 2024 18:38 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Inozyme Pharma Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 125.97m or -- of revenues. In addition the company used 70.68m for operations while cash used for investing totalled 53.65m.
Cash flow per share-1.45
Price/Cash flow per share--
Book value per share1.52
Tangible book value per share1.52
More ▼

Balance sheet in USDView more

Inozyme Pharma Inc has a Debt to Total Capital ratio of 32.44%, a higher figure than the previous year's 30.19%.
Current ratio9.84
Quick ratio--
Total debt/total equity0.4801
Total debt/total capital0.3244
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.